<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39404974</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0259</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Cardiovascular toxicology</Title><ISOAbbreviation>Cardiovasc Toxicol</ISOAbbreviation></Journal><ArticleTitle>Extracellular Volume and Fibrosis Volume of Left Ventricular Myocardium Assessed by Cardiac Magnetic Resonance in Vaccinated and Unvaccinated Patients with a History of SARS-CoV-2 Infection.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12012-024-09929-3</ELocationID><Abstract><AbstractText>Cardiac magnetic resonance (CMR) enables the assessment of tissue characteristics of the myocardium. Changes in the extracellular volume (ECV) and fibrosis volume (FV) of the myocardium are sensitive and early pathogenetic markers and have prognostic significance. The aim of the study was to assess ECV and FV of left ventricular myocardium in T1 mapping sequence in patients with a history of SARS-CoV-2 infection, considering vaccination status against COVID-19. The study group consisted of 97 patients (52.54 ± 8.31 years, 53% women and 47% men). The participants were divided into three subgroups: A) patients with a history of symptomatic SARS-CoV-2 infection, unvaccinated against COVID-19 (n = 39), B) patients with a history of symptomatic SARS-CoV-2 infection, with a full vaccination schedule against COVID-19 (n = 22), and C) persons without a history of SARS-CoV-2 infection constituting the control subgroup (C, n = 36). All patients underwent 1.5 T cardiac magnetic resonance. In subgroup A compared to subgroups B and C, both the ECV whole myocardium and ECV segments 2, 5-6, 8, and 10-11 were statistically significantly higher. In addition, the ECV segment 16 was statistically significantly higher in subgroup A than in subgroup C. Also, the FV whole myocardium was statistically significantly higher in subgroup A in comparison to subgroups B and C. There were no significant differences in ECV and FV between subgroups B and C. In summary, unvaccinated against COVID-19 patients with a history of symptomatic SARS-CoV-2 infection have higher myocardial ECV and FV values in the T1 mapping sequence, compared to those without COVID-19 and those suffering from COVID-19, previously vaccinated with the full vaccination schedule.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gać</LastName><ForeName>Paweł</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre of Diagnostic Imaging, 4th Military Hospital, Weigla 5, PL 50-981, Wroclaw, Poland. pawelgac@interia.pl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Environmental Health, Occupational Medicine and Epidemiology, Wroclaw Medical University, Mikulicza-Radeckiego 7, PL 50-368, Wroclaw, Poland. pawelgac@interia.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajdusianek</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, Occupational Medicine and Epidemiology, Wroclaw Medical University, Mikulicza-Radeckiego 7, PL 50-368, Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Żórawik</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Environmental Health, Occupational Medicine and Epidemiology, Wroclaw Medical University, Mikulicza-Radeckiego 7, PL 50-368, Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poręba</LastName><ForeName>Małgorzata</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paralympic Sports, Wroclaw University of Health and Sport Sciences, Witelona 25a, PL 51-617, Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poręba</LastName><ForeName>Rafał</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre of Diagnostic Imaging, 4th Military Hospital, Weigla 5, PL 50-981, Wroclaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Angiology and Internal Medicine, Wroclaw Medical University, Borowska 213, PL 50-556, Wroclaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiovasc Toxicol</MedlineTA><NlmUniqueID>101135818</NlmUniqueID><ISSNLinking>1530-7905</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiac magnetic resonance</Keyword><Keyword MajorTopicYN="N">Extracellular volume</Keyword><Keyword MajorTopicYN="N">Fibrosis volume</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vaccination status</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39404974</ArticleId><ArticleId IdType="doi">10.1007/s12012-024-09929-3</ArticleId><ArticleId IdType="pii">10.1007/s12012-024-09929-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shafiabadi Hassani, N., Talakoob, H., Karim, H., Mozafari Bazargany, M., &amp; Rastad, H. (2022). Cardiac magnetic resonance imaging findings in 2954 COVID-19 adult survivors: A comprehensive systematic review. Journal of Magnetic Resonance Imaging, 55(3), 866–880. https://doi.org/10.1002/jmri.27852</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.27852</ArticleId><ArticleId IdType="pubmed">34309139</ArticleId></ArticleIdList></Reference><Reference><Citation>Worldometers.info Dover DUSA, Accessed 2024.02.22. COVID‐19 Coronavirus Pandemic. https://www.worldometers.info/coronavirus/</Citation></Reference><Reference><Citation>Barreiro-Pérez, M., Pastor Pueyo, P., Raposeiras-Roubín, S., Montero Corominas, D., Uribarri, A., Eiros Bachiller, R., Rozado Castaño, J., García-Cuenllas Álvarez, L., Serratosa Fernández, L., Domínguez, F., &amp; Pascual, F. D. (2023). Myocarditis related SARS-CoV-2 infection or vaccination: An expert consensus statement on its diagnosis and management. Revista Española de Cardiología (Engl Ed)., 76(7), 555–563. https://doi.org/10.1016/j.rec.2023.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2023.01.011</ArticleId><ArticleId IdType="pmc">10008093</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudsen, B., &amp; Prasad, V. (2023). COVID-19 vaccine induced myocarditis in young males: A systematic review. European Journal of Clinical Investigation, 53(4), e13947. https://doi.org/10.1111/eci.13947</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13947</ArticleId><ArticleId IdType="pubmed">36576362</ArticleId></ArticleIdList></Reference><Reference><Citation>Feger J. Extracellular volume - myocardium. In: Radiopaedia.org. Radiopaedia.org, 2020. Epub ahead of print June 7, 2020. https://doi.org/10.53347/rID-78606</Citation></Reference><Reference><Citation>Moon, J. C., Messroghli, D. R., Kellman, P., Piechnik, S. K., Robson, M. D., Ugander, M., Gatehouse, P. D., Arai, A. E., Friedrich, M. G., Neubauer, S., Schulz-Menger, J., &amp; Schelbert, E. B. (2013). Society for cardiovascular magnetic resonance imaging; cardiovascular magnetic resonance working group of the European society of cardiology. Myocardial T1 mapping and extracellular volume quantification: A society for cardiovascular magnetic resonance (SCMR) and CMR working group of the European society of cardiology consensus statement. Journal of Cardiovascular Magnetic Resonance., 15(1), 92. https://doi.org/10.1186/1532-429X-15-92</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1532-429X-15-92</ArticleId><ArticleId IdType="pubmed">24124732</ArticleId><ArticleId IdType="pmc">3854458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira, V. M., Piechnik, S. K., Robson, M. D., Neubauer, S., &amp; Karamitsos, T. D. (2014). Myocardial tissue characterization by magnetic resonance imaging: Novel applications of T1 and T2 mapping. Journal of Thoracic Imaging, 29(3), 147–154. https://doi.org/10.1097/RTI.0000000000000077</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RTI.0000000000000077</ArticleId><ArticleId IdType="pubmed">24576837</ArticleId><ArticleId IdType="pmc">4252135</ArticleId></ArticleIdList></Reference><Reference><Citation>Treibel, T. A., White, S. K., &amp; Moon, J. C. (2014). Myocardial tissue characterization: Histological and pathophysiological correlation. Current Cardiovascular Imaging Reports, 7(3), 9254. https://doi.org/10.1007/s12410-013-9254-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12410-013-9254-9</ArticleId><ArticleId IdType="pubmed">25258658</ArticleId><ArticleId IdType="pmc">4169521</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang, J., Li, H., Xie, J., Yu, H., Chen, W., Yin, K., Chen, X., Sheng, Z., Zhang, X., &amp; Mu, D. (2022). Iodine-based extracellular volume for evaluating myocardial status in patients undergoing percutaneous coronary intervention for acute myocardial infarction by using dual-layer spectral detector computed tomography: A comparison study with magnetic resonance. Quantitative Imaging in Medicine and Surgery, 12(9), 4502–4511. https://doi.org/10.21037/qims-21-1103</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/qims-21-1103</ArticleId><ArticleId IdType="pubmed">36060604</ArticleId><ArticleId IdType="pmc">9403598</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti, C. B., Zanardo, M., Capra, D., Folco, G., Silletta, F., Secchi, F., &amp; Sardanelli, F. (2023). Myocardial extracellular volume assessment at CT in hospitalized COVID-19 patients with regards to pulmonary embolism. European Journal of Radiology, 163, 110809. https://doi.org/10.1016/j.ejrad.2023.110809</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2023.110809</ArticleId><ArticleId IdType="pubmed">37062205</ArticleId><ArticleId IdType="pmc">10079318</ArticleId></ArticleIdList></Reference><Reference><Citation>Markousis-Mavrogenis, G., Bacopoulou, F., Vlachakis, D., &amp; Mavrogeni, S. (2021). Tissue characterization in cardiology: Moving beyond function. Advances in Experimental Medicine and Biology, 1337, 89–97. https://doi.org/10.1007/978-3-030-78771-4_11</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-78771-4_11</ArticleId><ArticleId IdType="pubmed">34972895</ArticleId></ArticleIdList></Reference><Reference><Citation>Feger J. Myocardial fibrosis. In: Radiopaedia.org. Radiopaedia.org, 2020. Epub ahead of print June 11, 2020. https://doi.org/10.53347/rID-78789</Citation></Reference><Reference><Citation>Mewton, N., Liu, C. Y., Croisille, P., Bluemke, D., &amp; Lima, J. A. (2011). Assessment of myocardial fibrosis with cardiovascular magnetic resonance. Journal of the American College of Cardiology, 57(8), 891–903. https://doi.org/10.1016/j.jacc.2010.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.11.013</ArticleId><ArticleId IdType="pubmed">21329834</ArticleId></ArticleIdList></Reference><Reference><Citation>Schelbert, E. B., Sabbah, H. N., Butler, J., &amp; Gheorghiade, M. (2017). Employing extracellular volume cardiovascular magnetic resonance measures of myocardial fibrosis to foster novel therapeutics. Circulation Cardiovascular Imaging, 10(6), e005619. https://doi.org/10.1161/CIRCIMAGING.116.005619</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.116.005619</ArticleId><ArticleId IdType="pubmed">28512159</ArticleId></ArticleIdList></Reference><Reference><Citation>Poland’s Data Portal. https://dane.gov.pl/pl/dataset/2477,raport-zakazen-koronawirusem-sars-cov-2</Citation></Reference><Reference><Citation>Messroghli, D. R., Moon, J. C., Ferreira, V. M., Grosse-Wortmann, L., He, T., Kellman, P., Mascherbauer, J., Nezafat, R., Salerno, M., Schelbert, E. B., Taylor, A. J., Thompson, R., Ugander, M., van Heeswijk, R. B., &amp; Friedrich, M. G. (2017). Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the society for cardiovascular magnetic resonance (SCMR) endorsed by the European association for cardiovascular imaging (EACVI). Journal of Cardiovascular Magnetic Resonance, 19(1), 75. https://doi.org/10.1186/s12968-017-0389-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-017-0389-8</ArticleId><ArticleId IdType="pubmed">28992817</ArticleId><ArticleId IdType="pmc">5633041</ArticleId></ArticleIdList></Reference><Reference><Citation>Haaf, P., Garg, P., Messroghli, D. R., Broadbent, D. A., Greenwood, J. P., &amp; Plein, S. (2016). Cardiac T1 Mapping and extracellular volume (ECV) in clinical practice: A comprehensive review. Journal of Cardiovascular Magnetic Resonance, 18(1), 89. https://doi.org/10.1186/s12968-016-0308-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-016-0308-4</ArticleId><ArticleId IdType="pubmed">27899132</ArticleId><ArticleId IdType="pmc">5129251</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann, V. O., Peker, E., Chandrashekhar, Y., &amp; Nagel, E. (2016). T1 Mapping in characterizing myocardial disease: A comprehensive review. Circulation Research, 119(2), 277–299. https://doi.org/10.1161/CIRCRESAHA.116.307974</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.307974</ArticleId><ArticleId IdType="pubmed">27390332</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, C. A., Naish, J. H., Bishop, P., Coutts, G., Clark, D., Zhao, S., Ray, S. G., Yonan, N., Williams, S. G., Flett, A. S., Moon, J. C., Greiser, A., Parker, G. J., &amp; Schmitt, M. (2013). Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circulation Cardiovascular Imaging, 6(3), 373–383. https://doi.org/10.1161/CIRCIMAGING.112.000192</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.112.000192</ArticleId><ArticleId IdType="pubmed">23553570</ArticleId></ArticleIdList></Reference><Reference><Citation>Schelbert, E. B., Piehler, K. M., Zareba, K. M., Moon, J. C., Ugander, M., Messroghli, D. R., Valeti, U. S., Chang, C. C., Shroff, S. G., Diez, J., Miller, C. A., Schmitt, M., Kellman, P., Butler, J., Gheorghiade, M., &amp; Wong, T. C. (2015). Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. Journal of the American Heart Association, 4(12), e002613. https://doi.org/10.1161/JAHA.115.002613</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.115.002613</ArticleId><ArticleId IdType="pubmed">26683218</ArticleId><ArticleId IdType="pmc">4845263</ArticleId></ArticleIdList></Reference><Reference><Citation>Bing, R., &amp; Dweck, M. R. (2019). Myocardial fibrosis: Why image, how to image and clinical implications. Heart, 105(23), 1832–1840. https://doi.org/10.1136/heartjnl-2019-315560</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2019-315560</ArticleId><ArticleId IdType="pubmed">31649047</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin, C. W. L., Everett, R. J., Kwiecinski, J., Vesey, A. T., Yeung, E., Esson, G., Jenkins, W., Koo, M., Mirsadraee, S., White, A. C., Japp, A. G., Prasad, S. K., Semple, S., Newby, D. E., &amp; Dweck, M. R. (2017). Myocardial fibrosis and cardiac decompensation in aortic stenosis. JACC: Cardiovascular Imaging, 10(11), 1320–1333. https://doi.org/10.1016/j.jcmg.2016.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2016.10.007</ArticleId><ArticleId IdType="pubmed">28017384</ArticleId></ArticleIdList></Reference><Reference><Citation>Treibel, T. A., Kozor, R., Schofield, R., Benedetti, G., Fontana, M., Bhuva, A. N., Sheikh, A., López, B., González, A., Manisty, C., Lloyd, G., Kellman, P., Díez, J., &amp; Moon, J. C. (2018). Reverse myocardial remodeling following valve replacement in patients with aortic stenosis. Journal of the American College of Cardiology, 71(8), 860–871. https://doi.org/10.1016/j.jacc.2017.12.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.12.035</ArticleId><ArticleId IdType="pubmed">29471937</ArticleId><ArticleId IdType="pmc">5821681</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerqueira, M. D., Weissman, N. J., Dilsizian, V., Jacobs, A. K., Kaul, S., Laskey, W. K., Pennell, D. J., Rumberger, J. A., Ryan, T., &amp; Verani, M. S. (2002). American heart association writing group on myocardial segmentation and registration for cardiac imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American heart association. Circulation, 105(4), 539–542. https://doi.org/10.1161/hc0402.102975</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc0402.102975</ArticleId><ArticleId IdType="pubmed">11815441</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacking C, Goel A. Cardiac segmentation model. In: Radiopaedia.org. Radiopaedia.org, 2014. Epub ahead of print November 17, 2014. https://doi.org/10.53347/rID-32176</Citation></Reference><Reference><Citation>Małek, ŁA., Werys, K., Kłopotowski, M., Śpiewak, M., Miłosz-Wieczorek, B., Mazurkiewicz, Ł, Petryka-Mazurkiewicz, J., Marczak, M., &amp; Witkowski, A. (2015). Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy–comparison with late enhancement quantification. Magnetic Resonance Imaging, 33(6), 718–724. https://doi.org/10.1016/j.mri.2015.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mri.2015.04.001</ArticleId><ArticleId IdType="pubmed">25863138</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, J., Zhuang, B., Sirajuddin, A., Li, S., Huang, J., Yin, G., Song, L., Jiang, Y., Zhao, S., &amp; Lu, M. (2020). MRI T1 mapping in hypertrophic cardiomyopathy: evaluation in patients without late gadolinium enhancement and hemodynamic obstruction. Radiology, 294(2), 275–286. https://doi.org/10.1148/radiol.2019190651</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2019190651</ArticleId><ArticleId IdType="pubmed">31769741</ArticleId></ArticleIdList></Reference><Reference><Citation>Fries, R. C., Kadotani, S., Keating, S. C. J., &amp; Stack, J. P. (2021). Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy. Journal of Veterinary Internal Medicine, 35(2), 812–822. https://doi.org/10.1111/jvim.16067</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvim.16067</ArticleId><ArticleId IdType="pubmed">33634479</ArticleId><ArticleId IdType="pmc">7995366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ture, H. Y., Kim, N. R., &amp; Nam, E. J. (2023). New-onset retroperitoneal fibrosis following COVID-19 mRNA vaccination: Coincidental or vaccine-induced phenomenon? International Journal of Rheumatic Diseases, 26(7), 1368–1372. https://doi.org/10.1111/1756-185X.14621</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14621</ArticleId><ArticleId IdType="pubmed">36814401</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, T. C., Piehler, K., Meier, C. G., Testa, S. M., Klock, A. M., Aneizi, A. A., Shakesprere, J., Kellman, P., Shroff, S. G., Schwartzman, D. S., Mulukutla, S. R., Simon, M. A., &amp; Schelbert, E. B. (2012). Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation, 126(10), 1206–1216. https://doi.org/10.1161/CIRCULATIONAHA.111.089409</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.089409</ArticleId><ArticleId IdType="pubmed">22851543</ArticleId><ArticleId IdType="pmc">3464491</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, T. C., Piehler, K. M., Kang, I. A., Kadakkal, A., Kellman, P., Schwartzman, D. S., Mulukutla, S. R., Simon, M. A., Shroff, S. G., Kuller, L. H., &amp; Schelbert, E. B. (2014). Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. European Heart Journal, 35(10), 657–664. https://doi.org/10.1093/eurheartj/eht193</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht193</ArticleId><ArticleId IdType="pubmed">23756336</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, X., Wang, H., Zhao, R., Wang, T., Zhu, Y., Qian, Y., Liu, B., Yu, Y., &amp; Han, Y. (2021). Elevated extracellular volume fraction and reduced global longitudinal strains in participants recovered from COVID-19 without clinical cardiac findings. Radiology, 299(2), E230–E240. https://doi.org/10.1148/radiol.2021203998</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203998</ArticleId><ArticleId IdType="pubmed">33434112</ArticleId></ArticleIdList></Reference><Reference><Citation>Imran, A., Park, W. J., &amp; Sood, M. R. (2022). Partially resolving myocardial fibrosis five months following the mRNA COVID-19 vaccine: An MRI based case report. International Journal of Clinical Cardiology, 9, 253. https://doi.org/10.23937/2378-2951/1410253</Citation><ArticleIdList><ArticleId IdType="doi">10.23937/2378-2951/1410253</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., Loran, D., Hrncir, D., Herring, K., Platzer, M., Adams, N., Sanou, A., &amp; Cooper, L. T., Jr. (2021). Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiology, 6(10), 1202–1206. https://doi.org/10.1001/jamacardio.2021.2833</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2833</ArticleId><ArticleId IdType="pubmed">34185045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., Parker, M. A., &amp; Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiology, 6(10), 1196–1201. https://doi.org/10.1001/jamacardio.2021.2828</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2828</ArticleId><ArticleId IdType="pubmed">34185046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa Alhussein, M., Rabbani, M., Sarak, B., Dykstra, S., Labib, D., Flewitt, J., Lydell, C. P., Howarth, A. G., Filipchuck, N., Kealey, A., Colbert, J., Guron, N., Kolman, L., Merchant, N., Bandali, M., Bristow, M., &amp; White, J. A. (2022). Natural history of myocardial injury after COVID-19 vaccine-associated myocarditis. Canadian Journal of Cardiology, 38(11), 1676–1683. https://doi.org/10.1016/j.cjca.2022.07.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2022.07.017</ArticleId><ArticleId IdType="pubmed">35944800</ArticleId></ArticleIdList></Reference><Reference><Citation>John, B. V., Deng, Y., Schwartz, K. B., Taddei, T. H., Kaplan, D. E., Martin, P., Chao, H. H., &amp; Dahman, B. (2022). Postvaccination COVID-19 infection is associated with reduced mortality in patients with cirrhosis. Hepatology, 76(1), 126–138. https://doi.org/10.1002/hep.32337</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.32337</ArticleId><ArticleId IdType="pubmed">35023206</ArticleId></ArticleIdList></Reference><Reference><Citation>Okor, I., Bob-Manuel, T., Price, J., Sleem, A., Amoran, O., Kelly, J., Ekerete, M. F., Bamgbose, M. O., Bolaji, O. A., &amp; Krim, S. R. (2022). COVID-19 myocarditis: An emerging clinical conundrum. Current Problems in Cardiology, 47(9), 101268. https://doi.org/10.1016/j.cpcardiol.2022.101268</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2022.101268</ArticleId><ArticleId IdType="pubmed">35644500</ArticleId><ArticleId IdType="pmc">9135640</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>